|
Our Fungal Diversity provides
Chemical and Pharmacological Diversity
The approach used for isolation of the Mycosynthetix fungal collection has enabled us to assemble great diversity with Basidiomycete, Ascomycete, Zygomycete and Deuteromycete representation, including many slow-growing less common organisms, many of which remain unidentified and undoubtably include those not described in the literature.
A wide variety of biologically active compounds are produced by our fungi; we have documented activity against bacterial, viral, fungal and parasitic infectious disease targets, compounds with potential for cancer, diabetes and other metabolic disorders, transcription regulators with potential for a wide variety of targets including blood disorders such as anemia and sickle cell anemia, CNS associated targets, and a variety of agricultural targets. More details are provided elsewhere on this site, as well as in our publications, some of which are listed.
Fungi are extremely talented synthetic chemists and produce a wide variety of complex and simple metabolites derived from organic and fatty acids (for example polyketides), isoprene and terpenes, D and L amino acids, sugars and bases. See the link for some of the metabolites which have been identified from our fungi.
These vials illustrate some of the pigments produced by our fungi.
Fungi are a documented source of enzymes for commercial use: Mycosynthetix is seeking a partner to exploit our collection for new and better enzymes with industrial application.
Our fungal collection contains in excess of 55,000 isolates which together contain many millions of genes - please contact us to discuss your interest in this area.
Fungi produce one of the best known biofuels - ethanol. We believe that there are many potential biofuel applications for fungi and Mycosynthetix is exploring this in collaboration with MycoFuels Inc.
Home : :
Science & Technology : :
Current Projects
News & Publications : :
About Us : : Contact
|
